http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3759965-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 |
| filingDate | 1971-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1973-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf43cfbd8180cca3c7f564df997408ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f542004da3a91e045ae9c6f60b5cc7 |
| publicationDate | 1973-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-3759965-A |
| titleOfInvention | Pga{11 |
| abstract | This invention is a group of novel prostanoic acid derivatives, namely prostaglandin A2 (PGA2), prostaglandin A3 (PGA3), and 13,14-dihydroprostaglandin A1 (13,14-dihydro-PGA1), and the salts, esters, formates and alkanoates of those. These novel compounds are useful as antisecretory agents, vasodepressors, oxytocic agents, and abortifacients. These novel compounds are also useful to manage cases of renal disfunction and to regulate the menstrual cycle of women. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3900513-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3907871-A |
| priorityDate | 1971-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.